LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC

Update: 2025-08-29

Description

LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC by IASLC

Comments

In Channel

Lung Cancer Considered: • Rising Above: The Lung Cancer Hope Summit

2025-10-2146:09

LCC in Greek: WCLC 2025 Highlights

2025-10-1054:15

FDA Approval: Maintenance Lurbinectedin for SCLC

2025-10-0737:53

LCC in Arabic: WCLC 2025 Highlights

2025-10-0324:40

Lung Cancer Considered in Dutch: Targeting EGFR NSCLC

2025-10-0344:06

Lung Cancer Considered: Targeting EGFR NSCLC

2025-10-0344:06

Lung Cancer Considered in Japanese---2025 WCLC Highlights

2025-10-0234:51

LCC in Korean: WCLC 2025 Highlights

2025-09-3020:24

IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy

2025-09-2645:40

LCC in Mandarin: WCLC 2025 Highlights with Experts from Taiwan

2025-09-1849:37

LCC in Portuguese: WCLC 2025 Highlights

2025-09-1642:45

LCC in Spanish: WCLC 2025 Through a Junior Faculty Lens

2025-09-1123:02

LCC in Hebrew: WCLC 2025 Highlights

2025-09-1019:47

Live From WCLC 2025: Tuesday Highlights & Meeting Summary

2025-09-0943:49

LCC in Spanish: WCLC 2025 Highlights

2025-09-0940:07

Live From WCLC 2025: Monday Highlights

2025-09-0842:29

LCC in Mandarin: WCLC 2025 Highlights

2025-09-0835:32

Live From WCLC 2025: Sunday Highlights

2025-09-0724:29

"I'm in Barcelona, Now What?" — Tips for First-Time WCLC Attendees

2025-09-0619:07

LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC

2025-08-2952:17

00:00

LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC

#box-pro-ellipsis-176134498580877{-webkit-line-clamp:2;}LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC

LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC

IASLC

LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC